Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

41.47

-1.49 (-3.47%)

Apr 23, 2025, 4:00 PM EDT - Market closed

Monopar Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	3.16	3.23	2.95	2.63	2.44	Upgrade
Research & Development	13.01	5.6	7.59	6.49	4.07	Upgrade
Operating Expenses	16.16	8.83	10.54	9.13	6.51	Upgrade
Operating Income	-16.16	-8.83	-10.54	-9.13	-6.51	Upgrade
Interest & Investment Income	0.4	0.43	0.02	0.02	0.08	Upgrade
Other Non Operating Income (Expenses)	0.17	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-15.59	-8.4	-10.52	-9.1	-6.43	Upgrade
Other Unusual Items	-	-	-	-	0.12	Upgrade
Pretax Income	-15.59	-8.4	-10.52	-9.1	-6.3	Upgrade
Net Income	-15.59	-8.4	-10.52	-9.1	-6.3	Upgrade
Net Income to Common	-15.59	-8.4	-10.52	-9.1	-6.3	Upgrade
Shares Outstanding (Basic)	4	3	3	2	2	Upgrade
Shares Outstanding (Diluted)	4	3	3	2	2	Upgrade
Shares Change (YoY)	37.09%	8.70%	1.97%	13.82%	17.56%	Upgrade
EPS (Basic)	-4.11	-3.04	-4.13	-3.65	-2.88	Upgrade
EPS (Diluted)	-4.11	-3.04	-4.13	-3.65	-2.88	Upgrade
EBIT	-16.16	-8.83	-10.54	-9.13	-6.51	Upgrade

Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q